Article Details
Retrieved on: 2021-05-17 16:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
“Multiple available combinations of proteasome inhibitors, immunomodulators, and monoclonal antibodies are shifting the RRMM treatment landscape ...
Article found on: www.docwirenews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here